These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28745794)

  • 1. Expression of miR-210 in senile COPD complicating primary lung cancer.
    Li XX; Liu Y; Meng HH; Wang XW
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):38-42. PubMed ID: 28745794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
    Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
    Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression research of miR-210 in the elderly patients with COPD combined with ischemic stroke.
    Wang LQ; Wang CL; Xu LN; Hua DF
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4756-4760. PubMed ID: 27906445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
    Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
    Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Expression of MicroRNAs in Chronic Obstructive Pulmonary Disease.
    Kara M; Kirkil G; Kalemci S
    Adv Clin Exp Med; 2016; 25(1):21-6. PubMed ID: 26935494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers.
    Xie L; Wu M; Lin H; Liu C; Yang H; Zhan J; Sun S
    Mol Biosyst; 2014 May; 10(5):1072-81. PubMed ID: 24556821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD.
    Leidinger P; Keller A; Borries A; Huwer H; Rohling M; Huebers J; Lenhof HP; Meese E
    Lung Cancer; 2011 Oct; 74(1):41-7. PubMed ID: 21388703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
    de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung cancer in COPD--a clinical analysis].
    Maskey-Warzechowska M; Domagała-Kulawik J; Rubinsztajn R; Chazan R
    Pol Arch Med Wewn; 2002 Aug; 108(2):769-75. PubMed ID: 12476897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.
    Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():43-9. PubMed ID: 26766906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
    Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of miR-21 in peripheral blood serum and mononuclear cells in patients with chronic obstructive pulmonary disease and its clinical significance].
    Xie L; Yang F; Sun S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 41(3):238-43. PubMed ID: 27033786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miR-150-5p as a Biomarker for Chronic Obstructive Pulmonary Disease.
    Ding Y; Tang S; Zhou Z; Wei H; Yang W
    Int J Chron Obstruct Pulmon Dis; 2023; 18():399-406. PubMed ID: 36993790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease.
    Wang R; Li M; Zhou S; Zeng D; Xu X; Xu R; Sun G
    Int J Chron Obstruct Pulmon Dis; 2015; 10():463-73. PubMed ID: 25767384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors.
    Izquierdo JL; Resano P; El Hachem A; Graziani D; Almonacid C; Sánchez IM
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1053-8. PubMed ID: 25336937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.
    Ikari J; Nelson AJ; Obaid J; Giron-Martinez A; Ikari K; Makino F; Iwasawa S; Gunji Y; Farid M; Wang X; Basma H; Demeo D; Feghali-Bostwick C; Holz O; Rabe K; Liu X; Rennard SI
    PLoS One; 2017; 12(9):e0184039. PubMed ID: 28880936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underexpression of miR-486-5p but not Overexpression of miR-155 is Associated with Lung Cancer Stages.
    Mohamed MA; Mohamed EI; El-Kaream SAA; Badawi MI; Darwish SH
    Microrna; 2018; 7(2):120-127. PubMed ID: 29437031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.